https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
g., viral vascular endothelial growth factor) and cytokine mimics (e.g., viral interleukin 1 and/or inhibitors (e.g., tumor necrosis factor) have now been identified that target central immunological response pathways. We review here current development of virus-derived immune-modulating biologics with efficacy demonstrated in pre-clinical or clinical studies, focusing on pox and herpesviruses-derived immune-modulating therapeutics.Cardiovascular disease risk is increased in survivors of testicular cancer because of expos
Like
Comment
Share
